CONMED Statistics
Total Valuation
CONMED has a market cap or net worth of $1.31 billion. The enterprise value is $2.13 billion.
Important Dates
The last earnings date was Wednesday, January 28, 2026, after market close.
| Earnings Date | Jan 28, 2026 |
| Ex-Dividend Date | Sep 15, 2025 |
Share Statistics
CONMED has 30.97 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 30.97M |
| Shares Outstanding | 30.97M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 114.20% |
| Float | 30.68M |
Valuation Ratios
The trailing PE ratio is 28.03 and the forward PE ratio is 9.72. CONMED's PEG ratio is 1.86.
| PE Ratio | 28.03 |
| Forward PE | 9.72 |
| PS Ratio | 0.96 |
| Forward PS | 0.93 |
| PB Ratio | 1.30 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.86 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 45.17 |
| EV / Sales | 1.55 |
| EV / EBITDA | 8.05 |
| EV / EBIT | 11.18 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | n/a |
| Interest Coverage | 6.12 |
Financial Efficiency
Return on equity (ROE) is 4.77% and return on invested capital (ROIC) is 6.90%.
| Return on Equity (ROE) | 4.77% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.90% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.71% |
| Revenue Per Employee | $352,493 |
| Profits Per Employee | $12,065 |
| Employee Count | 3,900 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CONMED has paid $24.06 million in taxes.
| Income Tax | 24.06M |
| Effective Tax Rate | 33.83% |
Stock Price Statistics
The stock price has decreased by -37.12% in the last 52 weeks. The beta is 0.96, so CONMED's price volatility has been similar to the market average.
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -37.12% |
| 50-Day Moving Average | 41.09 |
| 200-Day Moving Average | 48.57 |
| Relative Strength Index (RSI) | 56.38 |
| Average Volume (20 Days) | 644,430 |
Short Selling Information
The latest short interest is 846,967, so 2.73% of the outstanding shares have been sold short.
| Short Interest | 846,967 |
| Short Previous Month | 1.02M |
| Short % of Shares Out | 2.73% |
| Short % of Float | 2.76% |
| Short Ratio (days to cover) | 3.99 |
Income Statement
In the last 12 months, CONMED had revenue of $1.37 billion and earned $47.06 million in profits. Earnings per share was $1.51.
| Revenue | 1.37B |
| Gross Profit | 785.17M |
| Operating Income | 190.21M |
| Pretax Income | 71.12M |
| Net Income | 47.06M |
| EBITDA | 264.11M |
| EBIT | 190.21M |
| Earnings Per Share (EPS) | $1.51 |
Full Income StatementBalance Sheet
The company has $38.93 million in cash and $853.75 million in debt, with a net cash position of -$814.82 million or -$26.31 per share.
| Cash & Cash Equivalents | 38.93M |
| Total Debt | 853.75M |
| Net Cash | -814.82M |
| Net Cash Per Share | -$26.31 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 32.57 |
| Working Capital | n/a |
Full Balance SheetMargins
Gross margin is 57.12%, with operating and profit margins of 13.84% and 3.42%.
| Gross Margin | 57.12% |
| Operating Margin | 13.84% |
| Pretax Margin | 5.17% |
| Profit Margin | 3.42% |
| EBITDA Margin | 19.21% |
| EBIT Margin | 13.84% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.60, which amounts to a dividend yield of 1.42%.
| Dividend Per Share | $0.60 |
| Dividend Yield | 1.42% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.74% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 1.42% |
| Earnings Yield | 3.59% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for CONMED is $51.20, which is 20.95% higher than the current price. The consensus rating is "Hold".
| Price Target | $51.20 |
| Price Target Difference | 20.95% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on September 10, 2001. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Sep 10, 2001 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
